Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

pembrolizumab 45 Carboplatin 40 Cisplatin 36 Paclitaxel 29 Pemetrexed 24 Nivolumab 24 Gemcitabine 23 Dexamethasone 21 Rituximab 18 Ipilimumab 16 Cyclophosphamide 15 Fluorouracil 14 Capecitabine 14 atezolizumab 13 Docetaxel 13 trastuzumab deruxtecan 12 durvalumab 12 Trastuzumab 12 Lenalidomide 12 daratumumab 11 Cytarabine 11 olaparib 10 Prednisone 10 Bortezomib 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 Doxorubicin 9 venetoclax 8 Oxaliplatin 8 Crizotinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has announcements × recombinant FVIIa × Clear all

NCT02622321 2021-06-24

HAVEN 1

Hoffmann-La Roche

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡